Nutragenomics Market

Nutragenomics Market Snapshot (2022 to 2032)

The global nutragenomics market size is expected to reach USD 2.11 Billion in 2032. The nutragenomics market is growing rapidly.

As per FMI Analysts, the global Nutragenomics market is estimated to be valued at USD 538.90 Million in 2022 and is projected to increase at a CAGR of 16.48% in the forecast period from 2022 to 2032.

Report Attribute	Details
Nutragenomics Market Estimated Base Year Value (2021)	USD 462.97 Million
Nutragenomics Market Expected Market Value (2022)	USD 538.90 Million
Nutragenomics Market Anticipated Forecast Value (2032)	USD 2.11 Billion
Nutragenomics Market Projected Growth Rate (2022 to 2032)	16.48% CAGR

The prevalence of genetic and chronic diseases has significantly increased so consumers are now being asked to take a nutragenomics test to find out if they have a preexisting or upcoming health issue due to eating a particular food product, driving growth in the nutragenomics market. Manufacturers are also attempting to use this process in order to understand a product's effect on its intended consumer before releasing it on the market.

The consumption of diets containing phenylalanine may interfere with the synthesis of proteins and enzymes. Kits of nutragenomics are also helpful in tracking nutritional consumption in a particular area or country. Nutragenomics manufacturers may be able to provide these tests at affordable prices. They may also try using other techniques for nutragenomics analysis; they may also consider the time duration of the analysis.

Nutragenomics manufacturers will be able to develop a rapid interaction detection technique between food and genes, as well as the interaction of nutrients with health and disease if manufacturers concentrate on regions involving Europe, Japan, and the USA for the maximum purchase of such products.

In addition, nutragenomics manufacturers can devise such kits and reagents that are easy for users to use, and results may be obtained in less time than other techniques. Nutragenomics may also be used to determine the amount of nutrient consumption in a particular area, as well as determine the toxicity of any products that may be used in the manufacture of foods that could be harmful to human health, registering high growth rates in the global nutrigenomics market.

Over the forecast period, North America is expected to lead the global nutrition genomics market, driven by the rapid adoption of personal genomics, the rising number of service providers, and the increasing prevalence of lifestyle-related diseases.

Companies like this are focusing on merging and collaborating with research facilities to develop ideal genetic tests. The main hurdle for manufacturers is developing better testing kits and having them approved by regulatory agencies. This is a change that will help fuel the nutragenomics market in the future.

Earlier this year, 23&Me teamed up with GlaxoSmithKline to research and developed innovative medicine, using genetics as the foundation to develop possible cures. To advance the understanding of human genetic diversity and to improve health outcomes for underrepresented populations in genetic research, 23&Me launched The Global Genetic Project in February 2018.

What are the Various Factors Driving the Nutragenomics Market?

The nutragenomics market has received a lot of traction in the industry.

Gene-related and chronic diseases are becoming more common, which is why some consumers are undergoing nutragenomics tests to understand their preexisting health conditions and any potential health issues that may occur if they consume a particular food product. Manufacturers are attempting to use nutragenomics to determine whether a product will have an adverse effect on the consumer before releasing it, creating demand for nutrigenomics.

Nutragenomics kits are useful for tracking nutrient intake amongst consumers in a particular area or country. Consumers should avoid consuming phenylalanine-containing foods since they could interfere with protein synthesis and enzyme synthesis.

Companies that specialize in these fields might be able to create tests at an affordable price, or they might be able to use other techniques rather than blood and saliva for nutragenomics analysis, or they might be able to reduce the time needed for the analysis.

The manufacturers of nutragenomics kits should consider targeting regions like Europe, Japan, and the USA so that their products can be sold in greater numbers, such as kits used for their stringent and precise regulation of any food material. Integrating biological data sets along with nutragenomics approaches could lead to the development of a rapid interaction detection technique between food and genes as well as the relationship between nutrients and health, resulting in an increase in sales of nutrigenomics.

What is Regional Analysis of Nutragenomics Market Share?

The North American nutrigenomics market is expected to outpace its global counterpart over the forecast period owing to the rapid adoption of personal genomics, the increase in the number of service providers, and the rising prevalence of lifestyle-related diseases.

It is predicted that the nutrigenomics market in Europe will expand during the forecast period as a result of increased research, strategic collaborations, and active government support.

The Asia Pacific is expected to drive notable growth in the nutragenomics market due to the large number of patients suffering from lifestyle diseases, in addition to lucrative pricing strategies being applied by various start-up companies in these regions.

According to a survey by a research institution in nine countries with 9000 participants, nutrigenomics has been widely accepted, and people are ready to adopt it if offered a legal guarantee that genetic data will not be misused. The Asia Pacific region is also expected to experience strong growth in the nutragenomics market due to the growing demand for functional foods and beverages that have elevated the adoption of nutrigenomic techniques.

What is the Competition Landscape in the Nutragenomics Market?

Some of the leading companies operating in the global nutragenomics market include Koninklijke DSM N.V., BASF SE, Danone SA, Genova Diagnostics, Inc., Nutrigenomix Inc., The Unilever Group, XCode Life Sciences Private Limited, WellGen, Inc., Integrative Medicine Communications. Inc., and Receptor Logic, Inc.

There are many companies that are focusing on acquiring and collaborating with various facilities for the development of ideal genetic tests. The development of better testing kits and their approval by regulatory bodies is the main hurdle facing all of these companies, and these changes will help propel the nutragenomics market growth in the future.

A collaboration between 23&Me and GlaxoSmithKline took place in June 2018. This collaboration will focus on investigating and developing innovative medicines and potential cures using human genetics as a starting point.

With the launch of The Global Genetic Project in February 2018, 23&Me seeks to improve its understanding of human genetic diversity and provide insights into health conditions that may affect populations underrepresented in genetic research, thereby affecting the growth rate in the global nutragenomics market.

Report Scope

Report Attribute	Details
Growth Rate	CAGR of 16.48% from 2022 to 2032
Base Year for Estimation	2021
Historical Data	2015 to 2021
Forecast Period	2022 to 2032
Quantitative Units	Revenue in USD Billion, Volume in Kilotons, and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered	Product Type, Technique, Application
Regions Covered	North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East and Africa
Key Countries Profiled	USA, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, Russia, Poland, Australia, New Zealand, China, India, Japan, South Korea, Thailand, Malaysia, Vietnam, Indonesia, GCC Countries, Turkey, South Africa, North Africa
Key Companies Profiled	Koninklijke DSM N.V.; BASF SE, Danone SA; Genova Diagnostics, Inc; Nutrigenomix Inc.; The Unilever Group; XCode Life Sciences Private Limited; WellGen, Inc.; Integrative Medicine Communications. Inc.; Receptor Logic, Inc
Customization	Available Upon Request

Key Segments Profiled in the Nutragenomics Market

By Product Type:

• Services
• Reagents & kits

By Technique:

• Blood
• Saliva
• Buccal Swab
• others

By Application:

• Diabetics
• Cardiovascular
• Anti-aging
• Chronic Disease
• Others

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa

Frequently Asked Questions

At what rate will the Nutragenomics Market Grow?

The global nutrigenomics market is set to exceed USD 2.11 Billion by 2032.

Which Region is set to lead the Nutragenomics Market?

The USA is projected to lead the nutrigenomics market in the forecast period.

Which are some of the Renowned Companies in the Nutragenomics Market?

Koninklijke DSM N.V., BASF SE, Danone SA, and Genova Diagnostics, Inc. are some of the renowned companies in the nutrigenomics market.